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Abstract
The dissemination of HIV from an initial site of infection is facilitated by motile HIV-infected CD4+ T-cells. However, the
impact of infected target cell migration on antigen recognition by HIV-specific CD8+ T-cells is unclear. Using a 3D in vitro
model of tissue, we visualized dynamic interactions between HIV-infected or peptide-pulsed CD4+ T-cells and HIV-specific
CD8+ T-cells. CTLs engaged motile HIV-infected targets, but ,50% of targets broke contact and escaped. In contrast,
immobilized target cells were readily killed, indicating target motility directly inhibits CD8+ T-cell function. Strong calcium
signals occurred in CTLs killing a motile target but calcium signaling was weak or absent in CTLs which permitted target
escape. Neutralization of adhesion receptors LFA-1 and CD58 inhibited CD8+ T-cell function within the 3D matrix,
demonstrating that efficient motile target lysis as dependent on adhesive engagement of targets. Antigen sensitivity (a
convolution of antigen density, TCR avidity and CD8 coreceptor binding) is also critical for target recognition. We
modulated this parameter (known as functional avidity but referred to here as ‘‘avidity’’ for the sake of simplicity) by
exploiting common HIV escape mutations and measured their impact on CTL function at the single-cell level. Targets pulsed
with low avidity mutant antigens frequently escaped while CTLs killed targets bearing high avidity antigen with near-perfect
efficiency. CTLs engaged, arrested, and killed an initial target bearing high avidity antigen within minutes, but serial killing
was surprisingly rare. CD8 cells remained committed to their initial dead target for hours, accumulating TCR signals that
sustained secretion of soluble antiviral factors. These data indicate that high-avidity CD8+ T-cells execute an antiviral
program in the precise location where antigen has been sensed: CTL effector functions are spatiotemporally coordinated
with an early lytic phase followed by a sustained stationary secretory phase to control local viral infection.
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Introduction
HIV, the causative agent of an ongoing global epidemic,
primarily infects CD4+ T lymphocytes [1]. Studies in humanized
mice and non-human primate models of HIV have revealed that
HIV-infected CD4+ T cells are motile and infected cell migration
and trafficking contribute to the spread of virus in vivo [2,3]. The
outcome of infection depends on a race between expansion of
infection versus containment by effective immune responses
[2,4,5,6]. HIV-specific CD8+ T cells contribute to control of
viremia in natural infection and following vaccination, but the
characteristics of protective responses are still being defined
[7,8,9,10]. The lysis and elimination of HIV-infected targets is
dependent on receptor-mediated signaling triggered during
physical contact with a target cell [11,12,13,14]. Notably, secretion
of soluble anti-viral factors by CTL also contributes to suppression
of viral replication in vitro [14]. In HIV-and SIV- infected subjects,
CTL polyfunctionality (the combination of lytic function and
secretion of multiple soluble factors by individual CTL) correlates
with long-term control of infection in vivo [15,16]. Furthermore,
the potent ex vivo ability of CTLs from individuals newly infected
with HIV to suppress viral replication has been identified as a
powerful predictor of low viral setpoint following acute infection
and a delayed progression to disease [17]. Intravital and whole-
organ imaging studies in mice have shown that CD8+ T cells
actively migrate through three-dimensional tissue compartments
in search of antigen [18,19], and the CTL response to non-motile
targets has been characterized [20,21,22]. However, the effect of
target cell migration (a circumstance particularly relevant to the
case of HIV infection) on the antiviral function of CTLs has not
been determined.
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The fundamentals of CTL function have been established in
traditional liquid suspension culture, but this in vitro approach does
not support the physiological migration that occurs within the
extracellular matrix (ECM). In the absence of migration, CTL-
target contact leads to immunological synapse (IS) formation [13]
and cytolytic killing is rapid (,15 minutes) upon recognition of a
few peptide-MHC-I on targets [23]. Such cytotoxic T lymphocytes
(CTLs) can kill multiple targets in liquid suspension [24,25] and it
has been proposed that effective CD8+ T cells may eliminate viral
infection in vivo through serial engagement and killing of many
targets [25,26,27]. However, the response of motile CTL to
migrating target cells has not been examined.
While CD8+ T cells are equipped with preformed stores of lytic
granules for rapid target killing [24,28,29] they also produce and
secrete anti-viral factors including cytokines and chemokines in an
‘‘on-demand’’ fashion. This response occurs over several hours in
liquid suspension cultures and requires sufficiently strong TCR
signals for induction of gene transcription and new protein
synthesis [30,31,32]. How migrating CD8+ T cells coordinate
these temporally-distinct anti-viral functions for effective protec-
tion of infected tissue microenvironments is not known.
Here we utilized a 3D collagen model of peripheral tissue to
support the migration of human HIV-specific CD8+ T cells and
HIV-infected target cells, a matrix that has been shown to
reconstitute immune cell engagement dynamics and function
strikingly similar to those observed in vivo [33,34,35]. Using a novel
videomicroscopy approach to capture $10 continuous hours of
cell migration and effector-target engagement dynamics, the
histories of individual cells were captured for both effector cells
and their targets. These experiments revealed two stages of CD8+
T cell dynamics that were coordinated with distinct phases of their
effector functions: An early ‘‘commitment phase,’’ marked by
engagement and killing of a motile target (,15 min), was followed
by a prolonged ‘‘secretory phase’’ lasting many hours. In the
secretory phase, CD8+ T cells accumulated TCR signals from
their initial killed target, remaining arrested and maintaining
contact with the dead target for 3–10 hrs or more; continued TCR
signaling during this phase was required for maximal secretion of
antiviral cytokines and chemokines. CD8+ T cells exhibiting high
functional avidity efficiently killed their targets and successfully
enter both the commitment and secretory phases. Conversely,
CD8+ T cells with low avidity not only permitted target escape
prompted by target cell migration, but also failed to mount a
robust secretory phase. These findings indicate that migration of
both target and effector cells impacts CD8+ T cell function, with
important implications for viral replication and dissemination of
HIV, which is predominantly an infection within tissues.
Results
In Situ Reporters Enabling Continuous Videomicroscopy
of CD8+ T Cells and Primary CD4+ Target Cells Migrating
in ECM
To directly observe the dynamics of CD8+ T cells engaging
migratory target cells we developed a fluorescence videomicro-
scopy strategy for extended-duration imaging of cells within 3D
type I collagen gels, simulating the 3D extracellular matrix
environment of tissues. HIV-specific, HLA class I-restricted CD8+
T cells (primary cells and Gag-specific clones E501 and A14) were
obtained from persons who spontaneously control HIV without
the need for medication. These CD8+ T cells were co-cultured in
collagen matrices with primary HLA-matched, activated CD4+ T-
cells infected with HIV-1 or pulsed with cognate peptides. To
distinguish target and effector cells, CD8+ T cells were labeled
with fluorophore-conjugated B subunits of Cholera toxin (CTXB,
the GM1-binding nontoxic subunit of CT, Figure 1A), which did
not affect CD8+ T cell function in standard chromium release
assays measuring CD8+ T cell killing of target cells (Figure S1A
in File S1). We employed a high speed-motorized stage to support
simultaneous imaging of up to 4 samples and acquisition of
internally-controlled data sets.
Primary HIV-specific CD8+ T cell lines and the HIV Gag-
specific CD8+ T cell clones A14 and E501 spontaneously polarized
and migrated within collagen matrices with speeds and persistent
random walk dynamics similar to those previously reported for T-
cells migrating in 3D collagen in vitro [35] and tissues in vivo
[3,18,19] (Figure 1B in File S1 and Video S1 in File S2).
Sorted GFP+ CD4+ T cells infected with a GFP-tagged HIV
construct (NL4-3-GFP) migrated in collagen with a reduced mean
velocity relative to uninfected CD4+ cells, but ,1/3 of the cells
maintained speeds comparable to uninfected primary CD4+ T
cells (6.060.37, mean 6 SEM), similar to recent reports of HIV-
infected human CD4+ T-cell migration in vivo in humanized mice
[3]. (Figure 1B). When CTLs and uninfected CD4+ T cells were
embedded together within collagen matrices using a ratio of one
CD8+ effector to 2 CD4+ T cells (E:T 1:2), antigen-independent
CTL-target encounters were frequent (mean hit rate of ,2
targets/hour) but brief (median of 7.2 min) and no killing of target
cells or sustained adhesive interactions were observed (Figure
S1B,C in File S1 and Video S2 in File S2). To visualize target
killing, the DNA-binding dye sytox was added to the collagen
matrix for in situ discrimination of live cells from dye-positive
permeabilized cells (Video S3 in File S2); cell death was also
typically obvious morphologically (Video S4 in File S2). When
CTL clones were embedded in collagen matrices with Gag
peptide-pulsed or control CD4+ target cells, videomicroscopy
revealed antigen-dependent killing of targets by CD8+ T cells
within collagen and continuous observation periods of at least
10 hrs were achieved with no evidence of phototoxicity to CTLs
or killing of antigen-free CD4+ cells (Figure 1C and data not
shown).
Migrating HIV-infected Target Cells Frequently Escape
from HIV-specific CTLs
We first characterized the early dynamics of CTLs interacting
with HIV-infected target cells, using the A14 and E501 CTL
clones obtained from persons who spontaneously control HIV
without the need for medications. HLA-matched CD4+ cells were
infected with NL4-3-GFP, sorted by flow cytometry for GFP+
infected cells, then embedded with E501 CD8+ T cells in collagen
matrices at a 1:2 E:T ratio and imaged over several hours.
Contacts between migrating CD8+ T cells and motile target cells
led to 4 characteristic types of interaction (Figure 2A): During
‘‘direct hit’’ kills, CTL engagement with a motile GFP+ target
triggered immediate motility arrest of both the effector and target
cell, followed by rapid target cell death with or without
permeabilization of the membrane (Figure 2A(i), Video S5 in
File S2). In more rare instances, upon target engagement and
CTL arrest, the target cell continued migration away from the
arrested CTL, often pulling a long tail of target cytoplasm as it
migrated. Eventually the tethered target stopped forward motion,
blebbed, and snapped back to the CTL as it was killed, in these
cases typically without permeabilization (‘‘successful tethers,’’
Figure 2A(ii), Video S6 in File S2). However, not all CTL
encounters with HIV-infected targets in the matrix led to target
death: During ‘‘failed tethers’’ CD8+ cells adhered to a target and
arrested, but the CD4+ cell continued to migrate, pulling long tails
of target cell cytoplasm before escaping (Figure 2A(iii), Video
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S7 in File S2). Finally, ‘‘Brushes’’ were defined as microscopically
observed contact between a motile HIV-infected target and a
CTL, without CTL arrest or reorientation of the CTL toward the
target (Figure 2A(iv), Video S8 in File S3).
Successful killing of infected targets was tightly linked with CTL
motility arrest (Figure S2 in File S1) and killing progressed with
a mean time of only 15 min to target blebbing and 92 min to
permeabilization (Figure 2B). However, only ,50% of E501
CTLs killed the first GFP+ target encountered in the matrix,
despite the fact that .95% of rested CTLs were armed with stores
of lytic granules (B27-KK10 tetramer+ GzmB+ by flow cytometry,
data not shown). We thus examined the behavior of the infected
targets more closely. While 47% of motile GFP+ targets were killed
by the first CTL to engage them, other infected targets were
engaged by multiple CTL over time but repeatedly escaped and
continued to migrate during 10 hours of observation (mean of 463
escapes per unkilled GFP+ target, Figure 2C).
To relate the escape of migrating targets to ability of these CTLs
to suppress virus in ECM, we next examined population-level
CD8+ T cell function in an in vitro assay of viral replication [14].
The anti-viral activity of both E501 and A14 Gag-specific clones
was compared within ECM gels and traditional liquid cultures,
where targets and effector cells are in constant close contact and
lack a migration-supporting matrix (Video S1 in File S2). Both
clones strongly inhibited viral replication in liquid co-culture with
infected CD4+ cells (Figure 2D). However, in parallel 3D
collagen co-cultures, the CTLs were much less effective at limiting
viral replication (p,0.0001, Figure 2D). Importantly, these
results do not reflect a lack of CTL-target encounters within
collagen as each CTL encounters an average of ,2 target cells per
hour in the matrix (Figure S1C in File S1). Thus, CTL antiviral
efficacy is reduced within ECM, a finding that correlates with the
ability of infected target cells to escape from migrating CTLs
within a 3D matrix environment.
To confirm that the dynamics observed with HIV-infected cells
were independent of infection-mediated changes in target cell
physiology, we carried out similar imaging analysis utilizing CD4+
targets pulsed with low nanomolar concentrations of synthetic
HIV peptides. The frequency of killing contacts for A14 CTLs
encountering targets (pulsed with cognate peptide Gag-SL9), as
evidenced by uptake of sytox, was antigen dose dependent,
(Figure 3A–B), elicited the same killing/escape contact dynamics
(Figure 3B), and the kinetics of killing events were similar to those
observed in response to HIV-infected targets (Figure 3C). Further
analysis of the duration of CTL-target engagements revealed
quantitatively different periods of contact for each dynamic/
outcome: direct hits on peptide-pulsed targets progressed to target
death in ,15–20 min, while killing of tethered targets was much
slower, taking on average 80 min (Figure 3D). By contrast,
antigen-pulsed targets that escaped from CTLs were in contact for
Figure 1. In situ reporters enabling continuous videomicroscopy of CTLs and primary CD4+ target cells in ECM. (A) Confocal images of
CTL clone A14 labeled with CTXB (red) migrating through 3D ECM (left: brightfield/CTXB fluorescence overlay, right: reflectance image of collagen
type I fibers). Scale bar 20 mm. (B) Mean velocities for individual cells tracked for one hour in collagen. HIV-specific CTLs (primary or clones), primary
uninfected CD4+ T cells or HIV-infected CD4+ T cells were cultured independently within ECM. CD4+ T cells were infected with HIV-1 NL4-3-GFP [61]
and flow-sorted to .95% GFP+ populations on day 3 post-infection. Shown is one representative of 3 independent experiments. Bars indicate mean
6 SEM. (C) A14 CTLs were co-cultured in ECM with HLA-matched primary CD4 targets (pulsed with 0 or 200 nM SL9 peptide). Antigen+/2 samples
were imaged in parallel at 1 min intervals for 10 hr with control samples imaged only at time 0 and 10 hr. Permeabilized target cells were assessed by
CTXB2 sytox+ cell counts (left panel) and live CD8+ T cells were assessed by CTXB+ sytox2 cell counts (right panel). Shown is 1 representative of 4
independent experiments.
doi:10.1371/journal.pone.0087873.g001
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only ,12 min in failed tethers or,5 min in brushes (Figure 3D).
Qualitatively similar results were obtained for the E501 CTL clone
(which recognized the synthetic gag KK10 peptide, data not
shown) and polyclonal primary CD8+ T cell lines (which
recognized pools of overlapping 18-mer peptides derived from
the sequences of gag, env, nef, and pol, Video S9 and S10 in
File S3). Taken together these data indicate that these dynamics
are CTL-intrinsic and apply not only to CTL clones but also
Figure 2. CTLs exhibit dynamic engagements with HIV-infected CD4+ target cells. (A–C) NL4-3-GFP HIV-infected CD4+ T cells (.95% GFP+)
were imaged in collagen with E501 CTLs (E:T ratio 1:2, 10 hr timelapse). (A) Contact types were characterized as (i) Direct hit kills, (ii) successful
tethers, (iii) Failed tethers, and (iv) brushes. Shown are representative velocity traces (CTL in red, target in black) and the period of CTL-target
engagement (live target in pink, morphologically dead target in gray, permeabilized target in green) vs. time for individual engagements of CTLs with
infected targets. (B) Time elapsed from initial contact until blebbing and/or permeabilization and total duration of CTL-target contact is shown for
engagements resulting in target death. (C) The number of escapes were enumerated for individual HIV-infected targets (n = 17 target cells analyzed).
Engagements resulting in target death (red) or target escape (white) are indicated. (D) JR-CSF HIV-infected CD4+ T cells were cultured in liquid media
or in ECM in the absence or presence of CTL clone A14 or E501 (E:T ratio 1:1) and HIV replication relative to infected cells alone was assessed by p24
ELISA after 2 days. Data are from one representative of 3 independent experiments. Bars indicate mean 6 SEM.
doi:10.1371/journal.pone.0087873.g002
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freshly isolated CD8+ T cells from infected persons, and do not
reflect HIV-specific alterations in target cells.
Target Cell Motility Impedes Antigen Recognition and
Directly Supports Target Escape
To determine whether the motility of target cells within the 3D
matrix environment per se reduced CD8+ T cell efficacy, peptide-
pulsed target cells were either allowed to migrate freely or were
immobilized on the glass substrate at the base of collagen gels with
anti-CD4 antibodies (Figure 4A). E501 CTL clones lysed 2.6-fold
more immobilized target cells than freely motile target cells after
10 hr (p,0.001, Figure 4B). Analysis of the number of CTL
engagements prior to target death revealed that immobilized
targets were most often killed upon their first encounter with a
CTL, but motile CD4+ targets escaped a mean of 2.960.4 CTLs
before being killed (Figure 4C). Death of non-immobilized CD4+
cells progressed with similar kinetics whether targets received a
lethal hit from the first CTL encountered or the nth CTL
(following escape from multiple CTLs), suggesting that failed
CTL-target engagements did not inflict cumulative, sub-lethal
damage (Figure S3A in File S1). The significant impact of target
cell motility on the efficiency of CTL killing was also observed for
EBV-transformed B cells bearing the same HIV peptide epitopes
(Figure S3B in File S1). Together these data indicate that target
migration directly impacts the efficiency of killing by CTLs in 3D
matrix.
CTL triggering and synapse formation is mediated by an
orchestrated rapid series of receptor engagements and downstream
signaling cascades. To determine where in this process CTL
triggering fails during target cell escape, we next characterized the
impact of target cell motility on intracellular calcium signaling, one
Figure 3. Peptide-pulsed targets elicit CD8+ T cell engagement dynamics similar to those observed for HIV-infected targets. A14
CD8+ T cells embedded with primary CD4+ T cell targets (pulsed with the indicated doses of peptide) within collagen gels were imaged for 10 hrs and
analyzed for CTL-target engagement dynamics (E:T ratio 1:2). (A) CTL killing activity (% sytox+ targets) vs. time as a function of antigen pulsing
concentration. Background cell death in the absence of added antigen primarily reflected a low level of spontaneous target cell apoptosis early in the
co-cultures. (B) Frequency of each type of CTL-target engagement during the first 30 minutes of co-culture as a function of antigen pulse
concentration. (C) Time elapsed from initial contact until blebbing and/or permeabilization and total duration of CTL-target contact is shown for
engagements resulting in target death (targets pulsed with 20 nM SL9 peptide). (D) Durations of characteristic CTL-target engagements determined
for targets pulsed with 20 nM SL9 peptide.
doi:10.1371/journal.pone.0087873.g003
Low Avidity CTLs Permit Escape of HIV+ Targets
PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e87873
of the earliest events downstream of TCR triggering. A14 CTLs
labeled with Fura-2AM engaging peptide-pulsed CD4+ targets
elevated intracellular calcium coincident with CD8+ T cell
migration arrest during both direct hit kills and successful tethers,
but direct hits were accompanied by calcium fluxes of greater
amplitude and duration that persisted post-target death
Figure 4. Target cell motility directly impacts CTL function. (A–C) CD4+ target cells (controls or pulsed with KK10 gag peptide) were spun to
the bottom of collagen matrices prior to gelation to allow binding to the underlying glass substrate, which was coated with anti-CD4 antibody and
ICAM or ICAM alone. E501 CTLs were added to the matrix (E:T ratio 1:2) and target/CTL dynamics were recorded by videomicroscopy for 10 hr. (A)
Wind-rose plots of target cell migration over a period of 20 min in the absence or presence of immobilizing anti-CD4. (B) Target cell death was
assessed by sytox fluorescence after 10 hr. (C) Engagement histories were recorded for motile or immobilized targets that were killed. (D, E) A14 CTLs
were loaded with FURA-2 AM and Ca2+ signaling was monitored for CTLs engaging peptide-pulsed CD4+ targets (2 nM SL9, 1 hr time-lapse). (D)
Shown are representative Ca2+ traces (blue) and instantaneous cell velocities (CTL in red, target in black) over time on the x-axis. The period of CTL-
target engagement is denoted on the time axis (live target in pink, killed in gray). (E) The presence or absence of Ca2+ signals was scored for CTL-
target engagements concluding with target death (n=89), a failed tether (n= 112), or a brush (n=95). Data pooled from 6 independent experiments.
Bars indicate mean 6 SEM.
doi:10.1371/journal.pone.0087873.g004
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(Figure 4D, E and Video S11 in File S3). In contrast, a weak
calcium flux was triggered in only 30% of CD8+ T cells engaging
in failed tethers, which terminated prior to target cell escape
(Figure 4D, E and Video S12 in File S3). Signaling was largely
absent during brushes (Figure 4D, E). Thus, tethering contacts
with migrating targets lasting tens of minutes did not ensure full
engagement of downstream TCR signaling, and target cell escape
was accompanied by a failure of strong/sustained calcium
signaling to be triggered in the CTL.
High TCR Avidity is Required for Efficient Engagement
and Killing of Targets in ECM
Our data suggest that within extracellular matrix, active
migration of CD4+ targets away from CTLs reduces the efficiency
of target cell killing, yet CD8+ T-cell responses can suppress viral
replication in vivo [9,36,37]. Since high functional avidity of CTLs
correlates with efficient viral suppression in vitro [38], we tested the
impact of CTL avidity at the single-cell level by measuring the
efficiency with which CTLs killed the first target cell contacted in
the matrix. To vary avidity in the absence of inter-clonal
differences in CTLs, we employed a panel of SL9 peptide variants
known to develop in HIV-infected patients that bind equivalently
to HLA-A2 [39]. In bulk chromium lysis assays in collagen, the
A2-restricted A14 CTLs recognized HLA-matched CD4+ target
cells pulsed with these SL9 variants with EC50s varying from
0.7 nM to 400 nM (Figure 5A). Strikingly, videomicroscopy of
these co-cultures revealed that A14 CTLs achieved first-contact
kill efficiencies of .90% in response to targets pulsed with low
concentrations (1–10 nM) of the SL9 peptides recognized with
high avidity (single mutant or wild-type). However, target cells
bearing peptides recognized with lower avidity showed a much
higher frequency of escape from these same CTLs, requiring ,10-
and ,1000-fold higher doses of double mutant or triple mutant
peptides, respectively, to elicit comparable first-contact killing
efficiencies (Figure 5B). Similarly, E501 CTLs, restricted by
HLA-B*2705 and exhibiting ,65-fold lower avidity for their
cognate peptide than A14 CTLs (Figure 5A), required nearly
100-fold higher antigen doses to achieve .50% first-contact-kill
efficiency against migrating targets in collagen (Figure 5B). These
data indicate that even when antigen is limiting, high avidity CTLs
are capable of catching and killing the first target encountered in a
3D matrix. Conversely, low avidity CTLs routinely failed to
successfully engage migrating targets at low antigen densities.
Adhesion Receptors CD58 and LFA-1 are Critical for CTLs
to Catch and Kill Targets in ECM
The presence of target cell tethering suggested that effective
target cell adhesion is a critical component of CTLs engaging
targets in a 3D tissue matrix. We thus quantified the importance of
key CTL/target adhesion molecules in mediating motile target cell
capture. Both A14 CTLs and primary CD4+ T-cell targets
expressed CD2, CD58, LFA-1, and ICAM-1 (data not shown).
Addition of blocking antibodies (for CD2, CD58, ICAM-1) or
small-molecule antagonists (for LFA-1 and the collagen receptor
VLA-4) to collagen matrix bulk killing assays showed that VLA-4
was not important for A14 CTL recognition of SL9-pulsed target
cells, but each of the cell-cell adhesion receptors tested played a
role in target cell killing, with combined blockade of LFA-1 and
CD58 leading to a ,85% reduction in killing (Figure 5C).
Videomicroscopy analysis of CD8+ T cell engagements with CD4+
targets in the presence of adhesion receptor blockade showed that
the frequency of A14 mediating direct hit kills decreased by ,5-
fold and the frequency of first-contact-kills decreased by ,4-fold
when LFA-1 was blocked compared to vehicle-treated controls;
combined LFA-1/CD58 blockade nearly eliminated all target cell
capture/killing (Figure 5D). Thus, CD8+ T cells exhibiting high
functional avidity can effectively capture migratory target cells in
extracellular matrix, in a manner dependent on effective adhesion
receptor engagement.
CTL Remain Committed to Killed Targets for Many Hours
Using the ability of the videomicroscopy assay to permit time-
lapse imaging of CTL-target interactions in collagen over
durations of many hours, we next characterized events occurring
beyond the first few encounters of CTLs with targets. Strikingly,
CTLs that engaged and killed HIV-infected targets remained
arrested in prolonged contact with dead targets for much longer
(mean of 3.060.4 hrs) than the time required for delivery of a
lethal hit (14.564.6 min to blebbing) (Figure 2B). Using Gag
peptide-pulsed target cells, the duration of engagement with killed
targets was found to be antigen dose-dependent, and the duration
of CTL-dead target contacts increased with increasing antigen
density (Figure 6A). At antigen doses eliciting substantial killing,
more than 10 hrs was required for CTL migration to resume
(Figure S4A in File S1), and disengaged CTL often remained in
the vicinity of their killed target for many hours (Video S13 in
File S3). Similar dynamics were observed for primary HIV-
specific CTL encountering CD4+ T cell targets and for the lower-
avidity E501 clone encountering CD4+ T cell targets and BCL
targets (data not shown). To determine whether TCR engagement
alone was sufficient to induce this long-lived arrest, we displayed
recombinant B27-KK10 peptide-MHC complexes on cell-sized
microspheres and analyzed the contact times of CD8+ T cells with
these beads in collagen. As shown in Figure 6B, E501 CTLs
migrating into contact with pMHC-displaying beads arrested and
remained engaged with beads for 6.761 hours, but interacted with
control beads for only 660.7 min indicating that prolonged arrest
was a CD8+ T cell-intrinsic response to TCR engagement.
Following commitment to an initial killed target, CD8+ T cells
engaged subsequent targets inefficiently. This was not due to a lack
of encounters or insufficient periods of observation since targets
frequently migrated over these arrested CD8+ T cells. Occasion-
ally, arrested CTLs caught and killed an additional CD4+ cell
within minutes or hours of killing their initial target (Figure 6C,
Figure S4B in File S1 and Video S14 in File S3), but the
large majority of encounters occurring over .10 hr between
migrating targets and arrested CD8+ T cells post-first-kill were
failures (brushes or failed tethers) (Figure 6C). Flow cytometry
analysis of CTLs co-cultured with targets indicated that, at the
antigen doses used, CTLs had not depleted their stores of lytic
granules (Figure S4C in File S1). Thus, after efficiently killing a
target, CD8+ T cells exhibit a TCR-dependent, CTL-intrinsic
program marked by many hours of arrested motility and
inefficient engagement of additional targets.
CD8+ T Cells Transition to Sustained Non-lytic Effector
Secretion during Prolonged Arrest
As CTL clones cultured in collagen with NL4-3-infected CD4+
cells produced substantial quantities of inflammatory chemokines
and cytokines by 12 hrs (data not shown), we hypothesized that
prolonged arrest on dead targets might reflect a transition of
engaged CTLs from a lytic to secretory phase. As noted above,
CD8+ T cells arrested on dead targets showed continued calcium
signaling after target death (Figure 4D). To determine whether
initial killing/CTL arrest coincided temporally with induction of
effector secretion, we measured the kinetics of cytokine/chemo-
kine secretion by CD8+ T cells engaging peptide-pulsed target cells
Low Avidity CTLs Permit Escape of HIV+ Targets
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in collagen. At an antigen dose (20 nM SL9) where .95% of A14
clones engaged a target and arrested within 30 min of co-culture
(Figure S5 in File S1), cytokine and chemokine secretion was
detected after 2 hr, as previously reported for CTL in liquid
cultures [12]. Secretion continued for at least 12 hr while these
CD8+ T cells remained arrested, leading to steady accumulation of
cytokines/chemokines in the culture (Figure 7A). However, if
TCR signals were attenuated by addition of an inhibitor of TCR
signaling (dasatinib) after 1 or 5 hours of co-culture, or by co-
culture of CTLs with targets bearing low-avidity peptides (20 nM
double mutant SL9), then CD8+ production of anti-viral cytokines
and chemokines was reduced (Figure 7B). Taken together, these
data indicate that CD8+ T cells require strong, prolonged TCR
signals for maximum effector secretion. Furthermore, they
coordinate their lytic and non-lytic effector functions spatiotem-
porally in ECM; target cell killing is followed by sustained arrest
on dead targets and upregulation of anti-viral effector molecule
secretion.
Discussion
Here we recorded the behavior of individual HIV-specific
CD8+ T cells starting with their first antigen encounter and
continuing for prolonged periods, up to 10 hr, within a 3D model
of peripheral tissue. This approach supported analysis of both
short- and long-term cellular dynamics, the latter of which are
presently inaccessible in vivo. This analysis revealed a coordinated
program of CD8+ T cell functions and migration dynamics that
evolves over time: Migrating CD8+ T cells surveyed 3D ECM in
search of antigen and, upon successful recognition, exhibited two
phases of antiviral function: a rapid ‘‘commitment phase’’ (target
engagement, adhesion, TCR signaling, migration arrest, target
killing) followed by a prolonged ‘‘secretory phase’’ (prolonged
migration arrest, prolonged TCR signal accumulation, sustained
effector molecule production).
While CD8+ T cell killing and secretory functions have been
well studied in vitro, how these functions are integrated with cell
migration dynamics has remained unclear. We found that HIV-
specific CD8+ T cells in ECM exhibit the initial cascade of
prototypical TCR-mediated events [23,40] and killing kinetics
[24,28,29] previously described for CTL in liquid cultures in vitro.
However, we also observed that migrating target cells are capable
of escaping from CTLs in ECM. Further, CD8+ T cells making a
successful kill did not immediately detach from dead targets upon
lethal hit delivery within ECM. Instead, CD8+ T cells remained
arrested (frequently .10 hr) and largely failed to engage and kill
Figure 5. High antigen sensitivity and adhesion receptors CD58 and LFA-1 are required for efficient killing of motile targets by
individual CD8+ T cells. CD8+ T cell clones were co-cultured in ECM with HLA-matched CD4+ targets (E:T ratio 1:2). (A) Functional avidities of A14
and E501 CTLs engaging targets in collagen were determined by 51Cr release assays, by determining EC50s (antigen pulsing concentration required
for 50% of max target death, for SL9 peptide and SL9 variants or KK10 peptide, respectively). (B) CTL efficiency was observed at the single-cell level (%
of individual CTL successfully engaging the first motile target encountered). Data pooled from 3–5 independent experiments, n for each condition
within each experiment was 10–30 CTL. Bars indicate mean 6 SEM. (C–D) A14 CTLs were co-cultured with HLA-matched CD4+ targets (pulsed with
2 nM SL9) within ECM in the presence of the indicated adhesion receptor antagonists (10 mg/mL neutralizing antibody or 50 nM inhibitor) or isotype
and vehicle controls. (C) CTL killing activity was measured by 51Cr release from targets after 6 hr of co-culture within ECM. Data pooled from 3
independent experiments. Bars indicate mean 6 SEM. (D) Frequencies of characteristic A14 CTL-target engagements during the first 30 minutes of
videomicroscopy.
doi:10.1371/journal.pone.0087873.g005
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subsequent passing targets, expanding upon short-term (30–
60 min) in vivo studies that report CTL arrest associated with
killing [18,21,41,42,43]. It should be noted that in studies of CTL
function, high antigen densities (achieved by pulsing targets with
micromolar concentrations of peptide) are frequently employed to
guarantee a measurable response. However, in the setting of HIV,
endogenously processed viral peptides can be presented at very
low antigen densities on target cells [44,45]. Thus, we focused on
the dynamics and function of the CTL response to HIV-infected
targets presenting physiologically relevant antigen and targets
bearing limiting doses of antigen (low nanomolar concentrations of
peptide).
HIV-infected CD4+ T cell migration has dire consequences
in vivo, supporting HIV replication and dissemination of viral
infection [2]. Here we have shown that motility directly supports
target escape even when CD8+ T cell contact occurs. However,
CD8+ T cells can and do contribute to spontaneous control of
HIV in rare individuals [7,32,46,47,48] and vaccine-induced
control in non-human primates [7,8,9,49]. Multiple dimensions of
CD8+ T cell activity have been correlated with control of HIV
in vivo: these include high lytic capacity [48], functional avidity
[50], b-chemokine expression [51,52], polyfunctionality (i.e. lytic
degranulation and non-lytic anti-viral effector molecule produc-
tion) [8,46], TCR usage [47] and proliferative capacity [48,50].
Figure 6. CTL exhibit a prolonged TCR-dependent, CTL-intrinsic migration arrest after successfully engaging and killing an initial
target. (A) A14 CTLs were co-cultured in collagen with CD4+ target cells pulsed with SL9 peptide (E:T ratio 1:2) and total engagement times for CTL-
target encounters ending in target death were recorded. Data shown from 1 representative of 5 independent experiments. Bars indicate mean 6
SEM. (B) The duration of E501 CTL engagements with 15 mm beads presenting recombinant B27-KK10 peptide-MHC complexes at a density of 20
pMHC/mm2 or control beads lacking pMHC in collagen was quantified by videomicroscopy. Data are from 1 representative of 4 independent
experiments. Bars indicate mean 6 SEM. (C) A14 CTLs were imaged in collagen with CD4+ T-cells pulsed with the indicated doses of SL9 peptide in
collagen (E:T ratio 1:2, 10 hr timelapse). Outcomes for each CTL engaging its first target or subsequent targets are expressed as % of first CTL
encounters or % of subsequent encounters (n=185 (0.1 nM SL9), 147 (2 nM SL9), and 308 (20 nM SL9) engagements analyzed). Data are pooled from
3 independent experiments.
doi:10.1371/journal.pone.0087873.g006
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Although these correlates of effective CD8+ T cell function have
been made, the current view of effector functions is kaleidoscopic.
An integrated program describing how individual CD8+ T cells
coordinate their multiple functions to eliminate a viral infection
remains unclear. We set out to define parameters that regulate
CD8+ T cell functions within 3D ECM over a 10 hr time-scale
encompassing early lytic and late secretory functions. Analysis of
these dynamics at the single-cell level revealed a new role for TCR
avidity in regulating the function of individual CD8+ T cells in the
context of cell migration: High-avidity cells were capable of near-
perfect efficacy in capturing and killing migrating targets on first
contact, while target cell motility facilitated escape from CD8+ T
cells under conditions of weak antigen recognition (low antigen
dose or low-avidity TCR/peptide-MHC interactions). Interest-
ingly, adhesion molecules LFA-1, CD2 and CD58 mediate
antigen-independent CTL-target conjugate formation in liquid
cultures [53] and LFA-1 is required for efficient TCR-dependent
killing mediated by directed release of lytic granules towards the
target cell [54]. Here we have shown that these molecules are
required to not only to support efficient antigen-dependent CTL
killing but also to prevent the escape of motile targets in a 3D
environment.
Furthermore, we found that the duration of effector-target
engagement is not pre-programmed but rather is controlled by
TCR signal strength, and that TCR signal accumulation continues
post-target-death. In liquid cultures, net TCR signals are
integrated over time [55] and CD8+ T cell functions are induced
according to a hierarchy of increasing TCR signaling thresholds
[28,32,56]. Our data suggest that strong early TCR signals
associated with killing trigger a positive feedback loop of prolonged
arrest, permitting greater net TCR signal accumulation that in
turn promotes greater induction and sustained secretion of effector
cytokines and chemokines (at least 12 hr). By contrast, weak TCR
signaling both makes initial target killing less efficient and also
results in poor effector function since TCR signal accumulation is
prematurely cut short by abandonment of the dead target. Thus,
strong TCR stimulation drives a program of spatially coordinated,
multidimensional (i.e., combined lytic and secretory) CD8+ T cell
function. Note that although our analysis shows that T cell
functional avidity is important, other aspects remain important,
such as the antigen targeted by the CTL: For example, although
the A14 CTL showed very efficient killing of peptide-pulsed
targets at very low antigen densities, it remained only modestly
better than the low-avidity E501 CTL clone in controlling viral
replication in collagen. This result is consistent with differences in
the antigen processing and presentation of the two epitopes in
infected cells [45].
The 3D ECM model system permitted detailed analysis of the
TCR-dependent CD8+ T cell-intrinsic program of functions,
however these results must be interpreted within the limitations of
our reductionist approach. We established conditions where the
phenotypic and functional characteristics of targets and killer cells
were well defined. Only two virus-specific clones and freshly-
primed CD8+ T cells from one patient were examined, but all gave
concordant results. This model system eliminates many variables
present in vivo, and many additional immune cells and mechanisms
contribute to the spread and/or control of virus in vivo [57]. For
example, the very long commitment of arrested CTLs to dead
targets observed here may be truncated at some time in vivo by
macrophages clearing apoptotic target cells. Since it is clear that
CD8+ T cells have the capacity to kill multiple targets if targets are
encountered simultaneously [31] and commit rapid, ‘‘serial kills’’
in suspension culture [24,58,59,60], we revisited this potential
mechanism in the present model. Individual CD8+ T cells were
observed for at least 10 hours, but killing of serially encountered
targets was rarely observed. Other cells or soluble factors could be
present in infected tissue that could influence cell motility and/or
CTL function, but notably, addition of potent motility-driving
chemokines such as CCL21 did not alter the sustained stop signal
behavior of CD8+ T cells here (data not shown).
Together, our findings lead us to propose a two-phase model for
control of infection by individual virus-specific CD8+ T cells
exhibiting cooperative behavior on the population level: On
detecting antigen, rather than attempting to control infection
individually through serial lytic hits, high-avidity CD8+ T cells
efficiently engage and kill initial targets (commitment phase).
Figure 7. CTLs rapidly transition from killing to sustained non-lytic effector secretion during prolonged arrest. A14 CTLs and peptide-
pulsed CD4+ target cells (20 nM SL9) were co-cultured in collagen (E:T ratio 1:2) and supernatants were harvested after the indicated time periods.
Concentrations of secreted cytokines/chemokines were analyzed using Flex Set bead-based ELISAs (BD Biosciences). Each data point reflects a unique
set of triplicate wells for each timepoint or condition. (A) Kinetics of cytokine/chemokine secretion were determined for CTL-target co-cultures or for
CTLs incubated alone over a 24 hour time period. (B) Target cells were pulsed with SL9 or double mutant SL9 peptide and co-cultured in the
presence or absence of the TCR signaling inhibitor dasatinib added after 1 hr or 5 hr of co-culture; secreted cytokine concentrations were assessed as
in (A). **** p,0.0001. Significance of data was determined by a 2 way ANOVA followed by a Bonferroni post test. Data shown are from 1
representative of 3 independent experiments. Bars indicate mean 6 SEM.
doi:10.1371/journal.pone.0087873.g007
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Killing is followed by a rapid transition to non-lytic effector
function, bathing the local microenvironment with antiviral
inflammatory factors (secretory phase). In this scenario, sustained
secretion of b-chemokines may rapidly shift the local E:T ratio, by
blocking infection of new targets and recruiting additional ‘‘ready-
to-kill’’ effectors into the tissue. Conversely, a population of low-
avidity CD8+ T cells will exhibit multifaceted failure: motile targets
will escape inefficient engagement, permitting viral replication and
spread, while upon killing a target, weak TCR signaling and
secretion of low quantities of b-chemokines insufficient for
blocking new infections might recruit additional CD4+ cells to
the tissue, thereby inadvertently promoting rapid viral replication
[2]. This mechanism for spatiotemporal coordination of antiviral
effector functions is dependent on CD8+ T cell killing efficiency
and highlights a new role for TCR avidity in tissue where effector
cells and target cells are motile. Thus, a successful HIV vaccine
employing CD8+ T cells would need to induce high-avidity CTL,
which can mount a cooperative and multidimensional response for
efficient elimination of migrating infected cells prior to over-
whelming virus dissemination.
Materials and Methods
Ethics Statement
The institutional review boards of Massachusetts General
Hospital and Massachusetts Institute of Technology approved
the studies of cells derived from human blood samples and all
human subjects gave written, informed consent.
Human Subjects
PBMCs were obtained from healthy donors (Research Blood
Components) and HIV-infected persons through outpatient clinics
at Massachusetts General Hospital, Brigham and Women’s
Hospital, and Fenway Health in Boston, MA. Primary HIV-
specific CTL were derived from subject 285873, an elite controller
with known HLA (A0201/A0301, B5101/B5101, Cw1402/
Cw1502), low viral load (,75 virions/mL), strong A2-SL9 specific
CTL responses (3600 SFC/106 PBMCs), and a broad CTL
response to optimal peptides (A2-SL9, A3-KK9, A3-RK9, A3-
RY10, Cw14-LL8 (p17), A2-VV9 (p24), A3-TK10 (gp120), A3-
RR11 (gp41), A2-SAV10 (env), A3-QK10 (nef), B51-LI9 (int),
B51-EI9, (vpr), B51-LI9 (gp160)) and individual 18-mer peptides
(recognizing 26/48 Gag, 9/13 Nef, 5/6 Tat, 8/24 Pol, 0/4 Vpr,
1/14 Env, 0/3 Vif overlapping 18-mer peptides) in traditional
ELISPOT assays. The E501 clone was derived from subject
828656, an elite controller with known HLA (A0301/2601;
B1501/2705; Cw0202/0303), pVL ,50 copies/ml, CD4 count
717 cells/ml, dominant B2705-KK10 responses with 3.68% KK10
tetramer+ cells in CD3+CD8+ population. A2-SL9 clone A14 was
generated from a controller with known HLA (A0201/A0301,
B0702/B4001, Cw0304/Cw0702), low viral load (96 copies/mL),
strong A2-SL9 specific CTL response (750 SFC/106 PBMCs), and
a broad CTL response to optimal peptides (A2-SL9 (p17), A2-
KK9 (p17), A3-RK9 (p17), A3-RR11 (gp41), B7-IL9 (gp41), B7-
GL9 (p24), B7-RV9 (nef), B40-IL10 (p17), B40-SL9 (p24), B40-
IL9 (RT), B40-QL10 (gp41), B40-KL9 (nef), Cw7-RY11 (nef) in
ELISPOT assays.
HIV-1 Virus Production
VSV-g pseudotyped virions. HEK293T cells were trans-
fected with pHDM-G vsv-g (Dr. Jeng-Shin Lee, Harvard Gene
Therapy Initiative) and pBR-NL43-IRES-eGFP-nef+ [61] or
pNL4–3 (AIDS Research and Reference Reagent Program,
NIAID, NIH; Cat #11349 deposited by Dr. F. Kirchhoff, or
Cat #114 deposited by Dr. M. Martin, respectively) with
LipoFectamine 2000 (Invitrogen) according to manufacturers’
instructions. Viral supernatant was harvested after 48 hr and
stored in aliquots at 280uC.
JR-CSF. Activated CD4+ T cells were infected with JR-CSF
(MOI 0.001) and incubated for 4–6 days. Viral supernatants were
stored in aliquots at 280uC.
Preparation of HIV-specific CTLs and Target Cells
CTL clones. The A14 (also referred to as 161jxA14) clone
and the E501 clone were previously described [62,63] and are
specific for A02-SL9 (gag p17) and B27-KK10 (gag p24),
respectively. CTL clones were maintained with periodic restim-
ulation and used in assays 12–20 days post-restimulation. For
imaging, CTLs were stained with 5 mg/mL Alexa 647-CTXB
(Invitrogen) in R10/50 medium for 30 min at 37uC, 5% CO2, and
washed twice. For calcium imaging, CTL were simultaneously
labeled with CTXB and Fura-2 AM (Invitrogen) at 20 mg/mL for
20 min at 37uC, 5% CO2 and imaged according to the
manufacturer’s instructions.
Primary polyclonal HIV-specific CD8+ T cells. CD8+ T
cells from individual 285873 were negatively selected (EasySep,
StemCell Tech.) from thawed PBMCs and primed with HLA-
matched CD4+ T cell targets pulsed with pools of overlapping 18-
mer peptides spanning the HIV-1 proteins Gag, Pol, Nef, Env.
Cultures received IL-2 (50 U/mL) on days 2, 5 and 12. Polyclonal
CD8+ T cells were used in assays on day 12.
Primary CD4+ T cell targets. CD8+ cells were separated
from PBMCs by positive selection (EasySep, StemCell Tech.) and
non-CD8 cells were activated with anti-CD3:8 (JT Wong,
Harvard Med. School), anti-CD28 (R&D Systems), and IL-2 for
5–7 days to generate primary CD4+ cell targets. Where indicated,
CD4+ T cells were pulsed with peptide for 1 hr at 37uC and
washed. Alternatively, CD4+ T cell targets were spinfected in
R10/50, polybrene (8 mg/mL) and HIV-1 (MOI of 0.001 to 0.1)
at 37uC, 2400 RPM (1220 g) for 2 hr and washed. For imaging
studies, infected populations were used directly when ,30% of the
cells were p24+ by flow cytometry (,3 days post-infection), or as a
purified infected population (.95% NL4-3-GFP+) 3 days post-
infection.
EBV-transformed B cell targets. Where indicated, BCL
expressing HLA-B27 were pulsed with KK10 (KRWIILGLNK,
for which 1 nM peptide is equivalent to 1.25 ng/mL) for 1 hr at
37uC, washed and used immediately in killing assays.
Peptides
SL9 (SLYNTVATL, or variants) for which 1 nM peptide is
equivalent to 1 ng/mL, and KK10 (KRWIILGLNK) for which
1 nM peptide is equivalent to 1.25 ng/mL were used at the
indicated concentrations. Overlapping 18-mer peptide pools
spanning the HIV-1 proteins Gag, Pol, Nef, Env were used at
concentrations of 100 ng/mL.
Viral Inhibition Assays
Primary activated CD4+ T cells spinfected with the R5-tropic
JR-CSF (MOI 0.01) were used as targets for their susceptibility to
both lytic and non-lytic (b-chemokine mediated inhibition of new
target infection via CCR5) CD8+ T cell functions. Targets were
established co-culture with CD8+ T cell clones immediately
following spinfection (E:T ratio 1:1). After 0 and 2 days of culture
in liquid or ECM in flat 96-well plates, triplicate samples were
lysed in wells with 1% triton X-100. HIV concentrations were
determined by p24 ELISA (Perkin Elmer) and viral replication was
calculated. The p24 concentrations from infected CD4+ T cells
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alone measured on day 0 and day 2 were used to define 0% and
100% replication, respectively.
Chromium Release Cytolysis Assays
CD4+ T-cell targets were 51Cr labeled (250 mCi/mL) and
peptide-pulsed for 1 hr at 37uC. Liquid and 3D collagen assays
were performed in triplicate in round-bottom 96 well plates at an
E:T ratio of 1:1 (16104 cells each) in a total volume of 200 ml. Co-
cultures and controls (MaxR, targets lysed with 3% Triton-X 100;
SR, targets alone) were packed by centrifugation (3 min, 300 g)
and incubated at 37uC, 5% CO2 for 4–6 hours.
51Cr was
measured in supernatants on a Packard Topcount. EC50s were
calculated following nonlinear regression (Prism, Graphpad
Software). % killed = (CPM2mean SR)/(mean MaxR CPM2
mean SR CPM)*100.
Time-lapse Microscopy of T-cells in 3D Collagen Matrix
8-well chambered coverglasses (Labtek, Nunc) were coated with
100 mg/ml fibronectin in PBS for 18 hr at 4uC, washed, and pre-
warmed (37uC) just prior to use. Neutral solutions of type I bovine
collagen (PurCol 5005, Advanced Biomatrix) containing sytox
green (Invitrogen, 5 mM in the final gel), RPMI, 10% FCS were
prepared following the manufacturer’s instructions on ice. Cells
(46104 effectors, 86104 targets) suspended in 400 mL neutral
collagen were deposited in coverglasses, centrifuged at 3006 g,
3 min. Samples were immediately imaged on a Zeiss Axiovert 200
epifluorescence microscope equipped with environmental control
(37uC, 5% CO2). Three images (sytox, CTXB, brightfield) were
collected every 1 min at 20X or 40X for 4 adjacent stage positions
in 4 parallel samples per imaging run (total field of view
134061800 mm per sample).
Immobilized Target Studies
8-well coverglasses (Labtech #1 glass, Nunc) were coated with
anti-CD4 (20 mg/mL OKT4 and RPA-T4, eBioscience) with or
without rhICAM-1 (1 mg/mL, R&D Systems) in PBS at 4uC for
18 hr. Slides were washed and prewarmed (37uC) prior to use.
Cells in collagen were then added to coated coverglasses as
described above.
Peptide-MHC-I Displayed on Cell-sized Beads
Streptavidin beads (Bangs Labs, CP01N, 15 mm) were rotated
at 4uC in the presence of biotinylated monomeric peptide-MHCI
complexes (KRWIILGLNK, HLA-B*2705: Dale Long, NIH
Tetramer Core Facility, Emory University) in PBS. After 2 hours,
the beads were washed with PBS, 0.1% BSA and used
immediately. The density of peptide-MHC-I on the surface of
beads (20 pMHC/mm2) was quantitated by staining with PE-
HLA-ABC (BD Biosciences) and comparing to Quantum Simply
Cellular anti-Mouse IgG beads (Bangs Labs, 815) according to the
manufacturer’s instructions.
Videomicroscopy Data Analysis
Image analysis was carried out using Metamorph (Molecular
Devices) and ImageJ (W.S. Rasband, NIH, Bethesda, Maryland)
imaging software. Timelapse imaging data from 4 adjacent
quadrants of each well were montaged for scoring of CTL-target
cell contacts. Instantaneous velocities for individual CTL were
recorded using the MtrackJ plugin (E Meijering, Biomedical
Imaging Group, University Medical Center Rotterdam, Nether-
lands) of ImageJ, and arrest coefficients were calculated as the
percentage of time that a cell’s instantaneous velocity was,2 mm/
min. Percentage of killed targets was calculated [% killed= (sytox+
targets at time 10 h – sytox+ targets at time 0)/sytox2 targets at
time 0].
Statistical Analysis
Data analysis was performed in Prism (Graphpad Software). p
values were calculated using two-way ANOVA followed by a
Bonferroni post-tests or with the Kruskal-Wallis nonparametric
one-way ANOVA test followed by a Dunn’s post-test.
Supporting Information
File S1 Contains Figure S1–S5. Figure S1. Related to Figure 1.
In situ reporters enabling continuous videomicroscopy of CTLs
and primary CD4+ target cells in ECM. (A) CTXB labeling does
not impair A14 CTL killing of peptide-pulsed targets in a
traditional 51Cr release assay in liquid culture. (B) Duration of
individual CTL-target engagements was quantified for A14 CTLs
and CD4+ T cells (without antigen) co-cultured in ECM and
imaged by videomicroscopy. Dotted line indicates the median,
with time in min (left axis) and hr (right). Bars indicate mean 6
SEM. (C) CTL hit rate defined as the number of CD4+ T cell
targets (without antigen) encountered by individual A14 CTLs per
hour determined from videomicroscopy analysis of A14 CTLs co-
cultured in ECM with antigen-free primary CD4+ T cells (E:T
ratio 1:2). Bars indicate mean 6 SEM. Figure S2. Related to
Figure 2. CTLs exhibit dynamic engagements with HIV-infected
CD4+ target cells. CTL arrest coefficients (defined as % of time
each CTL exhibited an instantaneous velocity of #2 mm/min)
were determined for individual CTL-infected target engagements
leading to HIV-infected target death or escape during hours 1–2 of
imaging. Data shown are from 1 representative of 3 independent
experiments. Bars indicate mean 6 SEM. Figure S3. Related to
Figure 4. Target cell motility directly impacts CTL function. (A)
Time required to deliver a lethal hit is not altered by prior failed
contacts of targets with CD8+ T cells. A14 CTLs were co-cultured
in collagen with peptide-pulsed CD4+ target cells (20 nM SL9) for
10 hr. The duration of the ultimately lethal CTL contact is shown
for targets killed by the first or nth A14 CTL encountered in the
matrix. (B) The impact of target motility on CTL function is not
limited to CD4+ T cell targets since a similar effect was observed
for motile B cell targets. BCL target cells (controls or pulsed with
KK10 gag peptide) were spun to the bottom of collagen matrices
prior to gelation to allow binding to the underlying glass substrate,
which was coated with anti-CD19 antibody and ICAM or ICAM
alone. E501 CTLs were added to the matrix (E:T ratio 1:2) and
target/CTL dynamics were recorded by videomicroscopy for
10 hr. Engagement histories were recorded for motile or
immobilized targets that were killed. Figure S4. Related to
Figure 6. CTL exhibit a prolonged TCR-dependent, CTL-
intrinsic migration arrest after successfully engaging and killing
an initial target. (A) CTL arrest coefficients after 2, 4, or 9 hr of co-
culture for A14 CTL engaging CD4+ T-cells (0, 0.1, 2, 20 nM
SL9) in collagen (E:T ratio 1:2, 10 hr timelapse). Data shown are
from 1 representative of 5 independent experiments. Bars indicate
mean 6 SEM. (B) Elapsed time between initial target cell killing
and subsequent target contacts for individual A14 CTL engaging
CD4+ T-cells (20 nM SL9) in collagen (E:T ratio 1:2, 10 hr
timelapse). Data shown are from 1 representative of 5 independent
experiments. Bars indicate mean 6 SEM. (C) CTLs retain large
stores of lytic enzymes at antigen doses eliciting significant CTL
activity. E501 CTL were incubated with KK10 peptide-pulsed
CD4 T cell targets in liquid culture for 6 hr and lytic granule
content was analyzed by flow cytometry. Plots are gated on CD8+
cells. Figure S5. Related to Figure 7: CTLs rapidly transition
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from killing to sustained non-lytic effector secretion during
prolonged arrest. A14 CTLs were co-cultured with antigen-pulsed
CD4+ T cell targets in collagen (E:T ratio 1:2) and imaged. The
percentage of CTL engaged with a target was assessed at the
indicated times.
(ZIP)
File S2 Contains videos S1–S7. Video S1. Related to Figure 1.
Target cell motility within collagen gels vs convection within
traditional liquid culture. CD4+ T cells were imaged within 3D
ECM (left panel) and in liquid culture (right panel). Elapsed time
shown in min:sec; scale bar 20 mm. Video S2.Related to Figure 1.
CTLs and target cells migrate within 3D ECM and CTL killing is
not observed in the absence of cognate antigen. A control culture
containing primary HIV-specific CTL and autologous CD4+ T
cells (not pulsed with any peptides) was imaged within 3D ECM.
CTL were stained with CTXB (red) and targets were unlabeled.
Dead cells are visualized with sytox green. Elapsed time shown in
hr:min; scale bar 20 mm. Video S3. Related to Figure 1. A target
cell is killed and permeabilized. The collagen matrix is infused
with the membrane-impermeable dye sytox, which selectively
fluoresces upon binding to DNA. Sytox permitted real-time
objective identification of permeabilized cells in situ, as dead targets
are marked by the rapid acquisition of green fluorescence. Shown
is one representative example of an A14 CTL (indicated with red
arrow) killing and permeabilizing a CD4+ T cell target (pulsed with
2 nM SL9 peptide, white arrow). Elapsed time is indicated in
hours:min. Scale bar 20 mm. Video S4. Related to Figure 1. A
target cell is killed and undergoes a ‘‘morphological death.’’ Not all
CTL killing of target cells was accompanied by permeabilization.
Non-permeabilizing kills were easily distinguished by morpholog-
ical signs of death, which included blebbing of the target
membrane and complete cessation of target movement. Shown
is one representative example of an A14 CTL (CTXB, red) killing
an unlabeled CD4+ T cell target (pulsed with 2 nM SL9 peptide).
Elapsed time is indicated in hours:min. Scale bar 20 mm. Videos
S5–S8. related to Figure 2. Recognition, engagement and killing
of HIV-infected target cells in ECM. E501 CTLs were co-cultured
in ECM with HLA-matched CD4+ T cell targets infected with
NL4–3 HIV virus. Permeabilized targets are visualized in situ with
sytox green. Videos S5, S7, and S8: target cells were from sorted,
HIV-infected populations (.95% NL4-3-GFP+). Video S6 was
acquired using an HIV-infected population of targets (,30%
p24+). The following cues are included: CTL, red arrow; target,
white arrow; elapsed time shown in min or hr:min; scale bar
20 mm. Video S5 A successful CTL-target engagement charac-
teristic of a ‘‘direct hit kill.’’ Video S6 A dramatic example of a
‘‘successful tether’’ followed by target death. Video S7 An
example of a target escape marked by a ‘‘failed tether.’’
(ZIP)
File S3 Contains videos S8–S14. Video S8 A failed CTL-target
engagement characteristic of a ‘‘brush.’’ Videos S9–S10. Related
to Figure 2 and 3. Primary HIV-specific CTL engage targets with
dynamics similar to those observed with CTL clones. Primary,
polyclonal HIV-specific CTL from subject 285873 were primed
with targets bearing overlapping 18-mer peptide pools covering
the full sequences of Gag, Pol, Nef, and Env. On day 14 the
polyclonal CTL were labeled with CTXB and seeded in 3D ECM
with autologous CD4+ T cell targets pulsed with the same peptide
pools (100 ng/mL). Target permeabilization is visualized with
sytox green. The following cues are included: CTL, red arrow;
target, white arrow; scale bar 20 mm. Elapsed time shown in
hr:min. Video S9 Primary CTL engages a target and commits a
direct hit kill. Video S10 Primary CTL exhibits a failed tether,
followed by target escape. Videos S11–S12. Related to Figure 4.
Target cell motility impedes antigen recognition. A14 CTLs were
double labeled with CTXB and the ratiometric calcium-sensing
dye FURA-2AM prior to loading in ECM. A14 CTLs engaged
HLA-matched CD4+ T cell targets pulsed with SL9 peptide
(2 nM). The following video cues are included: On the x-axis CTL
engagement with a live target is indicated in pink, prolonged CTL
engagement with a killed target is indicated in gray; CTL, red
arrow; target, white arrow; elapsed time shown in min; scale bar
20 mm. Video S11 CTLs exhibit prolonged TCR signaling
following a direct hit kill. The top video panel is a brightfield/
CTXB fluorescence overlay of CTL-target engagement dynamics.
TCR-dependent calcium signaling is represented in pseudocolor
video (bottom video panel) and is quantitatively expressed over
time as a normalized Fura ratio (right panel). Video S12 CTLs
exhibit weak TCR signaling during a failed tether. An A14 CTL
engages but fails to kill an antigen-pulsed CD4+ T cell. The left
video panel is a brightfield/CTXB fluorescence overlay of CTL-
target engagement dynamics. TCR-dependent calcium signaling is
represented in pseudocolor video (right panel) and is quantitatively
expressed over time as a normalized Fura ratio (bottom panel).
Video S13. Related to Figure 6. After a prolonged engagement
with a killed target, CTL disengages and exhibits durable
migration arrest. An A14 CTL (labeled with CTXB, red) was
observed to kill an HLA-matched CD4+ T cell target pulsed with
SL9 peptide (20 nM). The permeabilized target is marked with
sytox green. Shown is time-lapse imaging revealing prolonged
engagement with the killed target, followed by durable migration
arrest after CTL disengagement. Video S14. Related to Figure 6.
An A14 CTL engages, kills and permeabilizes an initial HLA-
matched CD4+ T cell target. While still arrested and engaged with
the initial killed target, the CTL catches and kills a subsequent
target. After ‘‘serially killing’’ two targets, this CTL remained
arrested and engaged with the killed targets, permitting escape of
three additional targets observed to run over the CTL. Targets
were pulsed with SL9 peptide (2 nM). Target permeabilization is
visualized with sytox green.
(ZIP)
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